Literature DB >> 24426428

Morphometric and histological study of breast lesions with special reference to proliferative activity and invasiveness.

Asim Kumar Manna1, Aparajita Samaddar2, Sumit Mitra2, Swapan Pathak2, Srabani Chakrabarti2, Diptendra Kumar Sarkar3.   

Abstract

Breast carcinoma is the most common cause of carcinoma death in women. Sometimes, difficulty arises to differentiate between premalignant lesions and carcinoma by routine histopathology. Our study was done to establish the role of morphometry and immunohistochemistry to solve this problem. In this study, total 60 cases of different breast lesions were included and 10 controls were also included to compare the results with the normal findings. They were studied by hematoxylin and eosin-stained sections for morphometry and routine histological study; as well as by proliferative markers such as proliferating cell nuclear antigen and p53. Invasiveness was studied using immunohistochemical staining with 34 βE12 monoclonal antibody. Statistically significant differences were found in morphometric parameters and in expression of proliferative markers between most of them. Morphometry and immunohistochemistry help in the proper diagnosis of different breast lesions that lie in the gray zone on routine histopathology.

Entities:  

Keywords:  Breast lesions; Markers of proliferative activity and invasiveness; Morphometry

Year:  2012        PMID: 24426428      PMCID: PMC3689373          DOI: 10.1007/s12262-012-0486-8

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  14 in total

1.  An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades.

Authors:  Balkrishna B Yeole; A P Kurkure
Journal:  Asian Pac J Cancer Prev       Date:  2003 Jan-Mar

2.  The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.

Authors:  M G Joshi; A K Lee; C A Pedersen; S Schnitt; M G Camus; K S Hughes
Journal:  Mod Pathol       Date:  1996-01       Impact factor: 7.842

3.  Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast.

Authors:  T Tanaka; M Kimura; K Matsunaga; D Fukada; H Mori; Y Okano
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

4.  Prognostic significance of immunohistochemical expression of p53 gene product in operable breast cancer.

Authors:  Hong Suk Song; Young Rok Do; Sun Hee Kang; Ki Yong Jeong; Yu Sa Kim
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

5.  PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

Authors:  E Leonardi; S Girlando; G Serio; F A Mauri; G Perrone; S Scampini; P Dalla Palma; M Barbareschi
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

6.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

Authors:  B A Robbins; D de la Vega; K Ogata; E M Tan; R M Nakamura
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

7.  Prognostic significance of p53 gene alterations in node-negative breast cancer.

Authors:  R M Elledge; S A Fuqua; G M Clark; P Pujol; D C Allred; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Nuclear morphometry of benign and malignant breast lesions.

Authors:  F Skjørten; R Kaaresen; U Jacobsen; P Skaane; E Amlie
Journal:  Eur J Surg Oncol       Date:  1991-08       Impact factor: 4.424

9.  Role of proliferative markers in breast lesions.

Authors:  Asim Kumar Manna; Swapan Pathak; Diptendra Kumar Sarkar
Journal:  Indian J Surg       Date:  2010-02-05       Impact factor: 0.656

10.  p53 expression in cytologic specimens from benign and malignant breast lesions.

Authors:  H Koutselini; A Malliri; J K Field; D A Spandidos
Journal:  Anticancer Res       Date:  1991 Jul-Aug       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.